Add new product for recognition to the main IVR.
AREXVY is a new vaccine to prevent RSV- route to vaccine queue for HCP IVR path, and product for applicable paths e.g. - side effect, PQC etc.
Also recognize the term "RSV Vaccine" and route the same, noting that these are related terms for future reference.
Pronunciation attached.
Vanity number for HCP brand.com site - AREXVY - (1-877-ARE-XVY1) = 1-877-273-9891
Can release sooner than 5/3/23
Priority | Medium |
Contact Center(s) | GRC |
Start date | Mar 17, 2023 |
Needed By | May 3, 2023 |
Closure Date | May 8, 2023 |
4/18/23 - Eric to have TFN ready to be in production on 5/3/23, but cannot be in production until the product is FDA approved which should receive notification on 5/3/23. <The remainder of this comment belongs in a separate IDEA for the routing.> Once Carol notifies Eric/Christie of approval, the number needs to go into production ASAP on 5/4/23 for calls to be directed to the front of the IVR for HCP menu options and routing.
Status Notes
3/24 Sent email requesting recording. Recording will be bundled with others.
3.26 Audio received and now attached.
4.14 Grammar file is done. Waiting on recordings - due back later today. Testing to be done on Monday.
5-May-2023 - Work completed and request for closure sent to Carol.
8-May-2023 - Closure approval received. See attachment.
Review Comments
Awaiting audio file from Carol